Kyle Reichl

Kyle Reichl is an accomplished chemist with extensive experience in medicinal chemistry. Currently serving as an Associate Principal Scientist at AstraZeneca since February 2020, prior roles include Senior Scientist at Amgen from February 2019 to December 2019, and Postdoctoral Researcher at Boston University from June 2016 to January 2019, where Kyle was recognized as an American Cancer Society Postdoctoral Fellow. Educationally, Kyle obtained a Doctor of Philosophy (PhD) in Chemistry from Penn State University and a Bachelor of Science (BS) in Chemistry from Lafayette College. Research guidance was provided by Prof. John A during the postdoctoral tenure.